• Small Molecules
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

Manufacturing vaccines during COVID-19

Introduction

The Healthcare sector was never in greater focus than in 2020. With the pandemic continuing unabated, the world looked to Science and the scientific community for deliverance. And Science did not disappoint. In less than a year of the pandemic, thanks to concerted global efforts, more than 150 vaccine candidates became available as a possible cure for COVID-19.

While 2020 was all about discovering a vaccine, 2021 is going to be about how to take the vaccines to market in the shortest possible time. With more than 2.6 million deaths worldwide (figures as on 9 March, 2021) and counting, the need for speed cannot underscored.

However, to decipher the manufacturing challenge, one needs to understand what goes behind producing a vaccine — raw materials, technology, and a complex manufacturing process. And finally, how and why Contract Manufacturing Organizations (CMOs)/ Contract Development and Manufacturing Organizations (CDMOs) are better positioned to bridge the gap between vaccine demand and supply, safely and at speed.

To view or email, Please share your details view

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details